COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies

BACKGROUND: Infections can trigger exacerbations of multiple sclerosis (MS). The effects of the coronavirus disease 2019 (COVID-19) on MS are not known. The aim of this study was to understand the impact of COVID-19 on new and pre-existing symptoms of MS. METHODS: The COVID-19 and MS study is an ong...

Descripción completa

Detalles Bibliográficos
Autores principales: Garjani, Afagh, Middleton, Rodden M, Hunter, Rachael, Tuite-Dalton, Katherine A, Coles, Alasdair, Dobson, Ruth, Duddy, Martin, Hughes, Stella, Pearson, Owen R, Rog, David, Tallantyre, Emma C, das Nair, Roshan, Nicholas, Richard, Evangelou, Nikos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585399/
https://www.ncbi.nlm.nih.gov/pubmed/34010764
http://dx.doi.org/10.1016/j.msard.2021.102939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585399/
https://www.ncbi.nlm.nih.gov/pubmed/34010764
http://dx.doi.org/10.1016/j.msard.2021.102939

Ejemplares similares